ArticleMolecular cancer2024

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.

Prashant Dogra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.